El-Osta H - Search Results

1

Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra).

El-Osta H, Janku F, Kurzrock R. El-Osta H, et al. Mol Cancer Ther. 2010 Jun;9(6):1485-8. doi: 10.1158/1535-7163.MCT-10-0156. Epub 2010 May 25. Mol Cancer Ther. 2010. PMID: 20501803 Free PMC article.

2

Castleman's disease: from basic mechanisms to molecular therapeutics.

El-Osta HE, Kurzrock R. El-Osta HE, et al. Oncologist. 2011;16(4):497-511. doi: 10.1634/theoncologist.2010-0212. Epub 2011 Mar 25. Oncologist. 2011. PMID: 21441298 Free PMC article. Review.

3

BRAF mutations in advanced cancers: clinical characteristics and outcomes.

El-Osta H, Falchook G, Tsimberidou A, Hong D, Naing A, Kim K, Wen S, Janku F, Kurzrock R. El-Osta H, et al. PLoS One. 2011;6(10):e25806. doi: 10.1371/journal.pone.0025806. Epub 2011 Oct 19. PLoS One. 2011. PMID: 22039425 Free PMC article.

4

Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.

El-Osta H, Hong D, Wheler J, Fu S, Naing A, Falchook G, Hicks M, Wen S, Tsimberidou AM, Kurzrock R. El-Osta H, et al. Oncologist. 2011;16(9):1292-8. doi: 10.1634/theoncologist.2011-0043. Epub 2011 Aug 22. Oncologist. 2011. PMID: 21859821 Free PMC article.

5

Predictors for clinical benefit of immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis.

El-Osta H, Jafri S. El-Osta H, et al. Immunotherapy. 2019 Feb;11(3):189-199. doi: 10.2217/imt-2018-0086. Immunotherapy. 2019. PMID: 30730276

6

A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion.

Circu ML, Dykes SS, Carroll J, Kelly K, Galiano F, Greer A, Cardelli J, El-Osta H. Circu ML, et al. PLoS One. 2016 Jan 19;11(1):e0146931. doi: 10.1371/journal.pone.0146931. eCollection 2016. PLoS One. 2016. PMID: 26784896 Free PMC article.

7

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

Circu M, Cardelli J, Barr MP, O'Byrne K, Mills G, El-Osta H. Circu M, et al. Among authors: el osta h. PLoS One. 2017 Sep 25;12(9):e0184922. doi: 10.1371/journal.pone.0184922. eCollection 2017. PLoS One. 2017. PMID: 28945807 Free PMC article.

8

Endobronchial Ultrasound for Nodal Staging of Patients with Non-Small-Cell Lung Cancer with Radiologically Normal Mediastinum. A Meta-Analysis.

El-Osta H, Jani P, Mansour A, Rascoe P, Jafri S. El-Osta H, et al. Ann Am Thorac Soc. 2018 Jul;15(7):864-874. doi: 10.1513/AnnalsATS.201711-863OC. Ann Am Thorac Soc. 2018. PMID: 29684288

9

Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study.

Jafri SH, Ali F, Mollaeian A, Mojiz Hasan S, Hussain R, Akkanti B, Williams J, Shoukier M, El-Osta H. Jafri SH, et al. Among authors: el osta h. Clin Med Insights Oncol. 2019 May 1;13:1179554919835798. doi: 10.1177/1179554919835798. eCollection 2019. Clin Med Insights Oncol. 2019. PMID: 31068757 Free PMC article.

10

Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.

Ansari J, Naqash AR, Munker R, El-Osta H, Master S, Cotelingam JD, Griffiths E, Greer AH, Yin H, Peddi P, Shackelford RE. Ansari J, et al. Eur J Haematol. 2016 Jul;97(1):9-16. doi: 10.1111/ejh.12755. Epub 2016 Apr 8. Eur J Haematol. 2016. PMID: 26990812 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters